Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Medicine and Dentistry
Chronic Kidney Disease
100%
Hemodialysis
48%
Cohort Analysis
33%
Kidney Graft
30%
Placebo
29%
Blood Pressure
29%
Bone Turnover
29%
Cardiovascular System
27%
ANCA Associated Vasculitis
27%
Osteoporosis
27%
Hyponatremia
26%
Kidney Function
24%
Kidney Transplantation
22%
Supplementation
21%
Glomerular Filtration Rate
18%
Cardiovascular Disease
18%
Parathyroid Hormone
18%
Hazard Ratio
18%
Arterial Stiffness
17%
Randomized Controlled Trial
16%
Combination Therapy
16%
Vascular Resistance
15%
Heart Failure
15%
Blood Vessel Calcification
14%
Diabetes
14%
Vitamin D
14%
Irbesartan
13%
Bone Biopsy
13%
Randomized Clinical Trial
13%
Biological Marker
13%
Chronic Kidney Disease-Mineral and Bone Disorder
13%
Nephrotic Syndrome
12%
Nephropathy
12%
Omega-3 Fatty Acid
12%
Diseases
12%
Systolic Blood Pressure
11%
End Stage Renal Disease
11%
Anticoagulation
10%
Cannulation
10%
Kidney Denervation
10%
Fluorine-18
10%
Immunoglobulin A Nephropathy
10%
Positron Emission Tomography-Computed Tomography
10%
Dialysis Fluid
10%
Sodium Bicarbonate
10%
Hemodynamic
10%
Magnesium
10%
Laboratory Medicine
10%
Apoplexy
10%
Drug Therapy
10%
Isotopes of Calcium
9%
Heart Rate Variability
9%
Insulin Sensitivity
9%
Procollagen
8%
Patient with Nephrotic Syndrome
8%
Antihypertensive Agent
8%
Angiotensin Receptor Antagonist
8%
Amino Terminal Sequence
8%
Biopsy
8%
Thrombin
8%
Atrial Fibrillation
7%
Renal Osteodystrophy
7%
Bone Disease
7%
Resistant Hypertension
7%
Bone Density
7%
Intervention Trial
7%
General Medicine
7%
Prevalence
7%
Essential Hypertension
7%
Renin Angiotensin Aldosterone System
7%
Ossification
7%
Prospective Cohort Study
7%
Pulse Wave Velocity
6%
Bone Mineralization
6%
Urinary System
6%
Aortic Pressure
6%
Cross Sectional Study
6%
Warfarin
6%
Bone Mass
6%
ICD-10
6%
Angiography
6%
Transplantation
6%
Symptom
6%
Diagnostic Performance
6%
Vasculitis
5%
Coronary Artery Disease
5%
Quality of Life
5%
Albuminuria
5%
Placebo-Controlled Study
5%
Peritoneal Dialysis
5%
Bleeding
5%
Alkaline Phosphatase
5%
Infection
5%
Vitamin K Deficiency
5%
Renal Artery
5%
Coronary Computed Tomography Angiography
5%
Cardiovascular Mortality
5%
All Cause Mortality
5%
Osteolysis
5%
Adverse Event
5%
Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
74%
Chronic Kidney Failure
29%
Hemodialysis
26%
Hyponatremia
15%
Placebo
15%
Randomized Controlled Trial
15%
Vitamin D
14%
All Cause Mortality
13%
Parathyroid Hormone
12%
Base
10%
Graft Failure
10%
Irbesartan
10%
Resistant Hypertension
10%
Patiromer
10%
Chronic Kidney Disease-Mineral and Bone Disorder
10%
Nephrotic Syndrome
10%
Biological Marker
9%
Cohort Study
8%
Atrial Fibrillation
7%
Peripheral Occlusive Artery Disease
7%
Cardiovascular Disease
7%
Alkaline Phosphatase
7%
Comorbidity
6%
Disease
6%
Aldosterone
6%
Renin
6%
Angiotensin
6%
Cardiovascular Risk
6%
Cardiovascular Disease
6%
Anticoagulant Agent
6%
Prevalence
6%
Cross Sectional Study
6%
Sudden Cardiac Death
6%
Hypotension
6%
Warfarin
6%
Albuminuria
5%
Fatty Acid
5%
Antihypertensive Agent
5%
Hip Fracture
5%
Infection
5%
Icosapentaenoic Acid
5%
Intervention Trial
5%
Normal Human
5%
Polyunsaturated Fatty Acid
5%
End Stage Renal Disease
5%
Intervention Study
5%
Pyelonephritis
5%
Hyperkalemia
5%
Vitamin K Deficiency
5%
Eculizumab
5%
Obesity
5%
Angiotensin Receptor
5%
Rheumatoid Arthritis
5%
Myeloblastin
5%
Transgenic Crop
5%
Matrix Protein
5%
Angiotensin Receptor Antagonist
5%
Masked Hypertension
5%
Acute Respiratory Failure
5%
Heart Arrhythmia
5%
Osteoprotegerin
5%
Sodium Ion
5%
Hypernatremia
5%
Secretoneurin
5%
Cathepsin
5%
Side Effect
5%
Antivitamin K
5%
Autonomic Neuropathy
5%
Artery Calcification
5%
Glomerulonephritis
5%
Antibiotic Therapy
5%
Haptoglobin
5%
Apixaban
5%
Iron Saccharate
5%
Symptom
5%
Iron Isomaltose
5%
Proprotein Convertase 9
5%
Ubiquinol
5%
Ubidecarenone
5%
Heart Failure
5%
ANCA Associated Vasculitis
5%
Psoriatic Arthritis
5%
Essential Hypertension
5%
Low Density Lipoprotein
5%
Docosahexaenoic Acid
5%
Keyphrases
Chronic Kidney Disease
26%
Cardiovascular Events
19%
ANCA-associated Vasculitis
18%
N-3 Polyunsaturated Fatty Acids
17%
Hemodialysis
17%
Confidence Interval
13%
Kidney
13%
Kidney Transplantation
13%
Hazard Ratio
12%
Intradialytic
10%
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
10%
Patiromer
10%
Cardiovascular Mortality
10%
Consensus Statement
10%
High Risk
7%
All-cause Mortality
7%
Major Adverse Cardiovascular Events
7%
Chronic Kidney Disease Stage
7%
Chronic Kidney Disease-mineral
7%
Mineral Disorders
7%
Bone Disorders
7%
Plasma Exchange
7%
Dialysis
6%
Hemodialysis Patients
6%
Renin-angiotensin-aldosterone System
6%
Osteoporosis
6%
Non-associated
6%
Albuminuria
6%
Maintenance Hemodialysis
6%
Cardiovascular Risk
6%
Multicenter Cohort Study
6%
Analytical Approach
5%
Vitamin D Supplementation
5%
Plasma Magnesium
5%
Bloodstream Infection
5%
Central Hemodynamics
5%
Insulin Sensitivity
5%
Rheumatoid Arthritis Protocol
5%
Coronary CT Angiography
5%
Omega-3 Fatty Acids
5%
Marine Fatty Acids
5%
Coagulation Function
5%
Hyperkalemia
5%
Anephric
5%
Oily Fish
5%
Peripheral Vascular Resistance
5%
Parental Influence
5%
Hypomagnesemia
5%
Improved Survival
5%
Nephrotic Syndrome
5%
Offspring of Hypertensive Parents
5%
Life Cycle Methodologies
5%
Crop Production Technologies
5%
Endothelial Function
5%
Venovenous
5%
Metformin Poisoning
5%
Vertebral Fracture
5%
Hemofiltration
5%
Intermittent Hemodialysis
5%
Factorial Randomized Trial
5%
Atypical Hemolytic Uremic Syndrome (aHUS)
5%
Buttonhole
5%
Buttonhole Cannulation
5%
Eculizumab
5%
Crescentic IgA Nephropathy
5%
IgA Nephropathy (IgAN)
5%
Quantity of Life
5%
Conservative Kidney Management
5%
Multiplexed Proteomics
5%
Predictors of Infection
5%
Dialysate Bicarbonate
5%
Irbesartan
5%
Kinetic Model
5%
Poisoning
5%
Postmenopausal Women
5%
Angiotensin Receptor Blockade
5%
Proteinase 3
5%
Rheumatoid Arthritis
5%
Autoimmune Vasculitis
5%
National Osteoporosis Foundation
5%
Nephronophthisis
5%
Module Linking
5%
Newly Diagnosed Hypertension
5%
Online Hemodiafiltration
5%
ANKS6
5%
High-flux Hemodialysis
5%
NEK8
5%
NPHP3
5%
European Consensus
5%
Therapy Assessment
5%
Acute Respiratory Failure
5%
Home BP
5%
Unattended Automated Office Blood Pressure
5%
Failure Impact
5%
Dosing Guidelines
5%
Atherosclerotic Renovascular Disease
5%
Living Donor Kidney Transplantation
5%
Renal Artery Stenting
5%
Nutritional Vitamin D
5%
Clinical Review
5%